Evidence map›Paper›PMID 40143114›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Synthesis, Anti-Inflammatory, and Molecular Docking Studies of New Heterocyclic Derivatives Comprising Pyrazole, Pyridine, and/or Pyran Moieties.

Mohamed A M Abdel Reheim, Hend S Abdel Rady, Omnia A Mohamed, Abdelfattah Hassan, Ibrahim S Abdel Hafiz, Hala M Reffat, Fahmy Gad Elsaid, Mamdouh Eldesoqui, Dalal Sulaiman Alshaya, Abdelnaser A Badawy and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pyrazole Derivatives as Selective COX-2 Inhibitors: An Updated Review.Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2026
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mohamed A M Abdel ReheimDepartment of Chemistry, Faculty of Science, Arish University, Arish 45511, Egypt.
Hend S Abdel RadyDepartment of Chemistry, Faculty of Science, Arish University, Arish 45511, Egypt.
Omnia A MohamedDepartment of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, Egypt.ORCID 0009-0001-9804-1251
Abdelfattah HassanDepartment of Medicinal Chemistry, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt.ORCID 0000-0001-8539-662X
Ibrahim S Abdel HafizDepartment of Chemistry, Faculty of Science, Arish University, Arish 45511, Egypt.
Hala M ReffatDepartment of Chemistry, Faculty of Science, Arish University, Arish 45511, Egypt.
Fahmy Gad ElsaidDepartment of Biology, College of Science, King Khalid University, P.O. Box 960, Abha 61421, Saudi Arabia.ORCID 0000-0002-7754-2524
Mamdouh EldesoquiDepartment of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O. Box 71666, Riyadh 11597, Saudi Arabia.ORCID 0000-0002-6589-4514
Dalal Sulaiman AlshayaDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-0682-8189
Abdelnaser A BadawyDepartment of Biochemistry, Faculty of Medicine, Northern Border University, P.O. Box 1321, Arar 91431, Saudi Arabia.
Eman FayadDepartment of Biotechnology, College of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Aboubakr H AbdelmonsefDepartment of Chemistry, Faculty of Science, South Valley University, Qena 83523, Egypt.ORCID 0000-0002-4616-0224

Funding

AlMaarefa University MHIRSP2024009Deanship of Scientific Research and Graduate Studies at King Khalid University RGP2/63/46Deanship of Scientific Research at Northern Border University NBU-FFR-2024-52-01Princess Nourah bint Abdulrahman University PNURSP2025R465
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-inflammatoryClaisen–Schmidt reactionMichael additionmolecular dockingpyranpyrazolepyridine

Identifiers

PMID40143114
PMCPMC11944836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.